CTLA ‐4 polymorphism rs231775: influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood
ConclusionThis study suggests that CTLA ‐4 polymorphism rs231775 is relevant for relapse and survival after allogeneic HSCT in childhood and should be further investigated in clinical trials.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - Category: Hematology Authors: Judith Hammrich,
Susan Wittig,
Thomas Ernst,
Bernd Gruhn Tags: Original Article Source Type: research
More News: Acute Leukemia | Children | Clinical Trials | Genetics | Hematology | Leukemia | Stem Cell Therapy | Stem Cells | Study | Transplants